Clinical Trials Arena May 30, 2024
The cell and gene therapy market is gathering speed, in its evolution as well as commercial approvals, presenting patients with new therapeutic options.
The progress of advanced therapeutics in recent years, especially in oncology, have been so promising many are starting to use the term “cure” when talking about some types of cancer. Despite complex manufacturing processes, multiple cell and gene therapies are providing front-line treatment options, with others continuing to move closer to front-line.
In many cases, producing a cell therapy involves modifying primary immune cells to recognize, seek out, and attack specific cancer cells, which can co-opt immunosuppressive mechanisms to evade the body’s immune defenses.
As scientific understanding develops in parallel with technological advances, the next generation of...
Today's Sponsors
Today's Sponsor